Revista espanola de cardiologia最新文献

英文中文

Estilo de vida y riesgo cardiovascular de jóvenes trabajadores: hallazgos en una cohorte de toda España 青年工人的生活方式与心血管风险：西班牙全境队列研究结果

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-06-01 DOI: 10.1016/j.recesp.2024.02.006

Introduction and objectives

This study aimed to describe the cardiovascular risk profile of working young adults from Spain and its association with lifestyle.

Methods

Participants (18-30 years) were recruited from a nationwide cohort of economically active adults insured by a large occupational risk prevention company, with data obtained from routine medical assessments. The participants were categorized as having an “unhealthy” cardiovascular risk profile based on the presence of prediabetes/diabetes, prehypertension/hypertension, or hypercholesterolemia, or a “healthy” profile if these conditions were completely absent. The association with lifestyle factors (weight, physical activity, sleeping characteristics, alcohol consumption, smoking) was assessed.

Results

A total of 78 421 young adults (27 ± 2 years, 36% female) were evaluated at baseline. The “unhealthy” cardiovascular risk profile was prevalent (18%) and inversely associated (OR, 0.64; 95%CI, 0.57-0.80) with an optimal lifestyle (normal weight, regular physical activity, no drinking/smoking, and good sleep). The latter condition was found in only 3.5% of the participants. On the other hand, prospective analyses in 44 776 participants (median follow-up = 2 [range 2-5] years) showed that 2.0% transitioned from a “healthy” to an “unhealthy” profile. Being physically active (OR, 0.95; 95%CI, 0.81-0.99) and having a normal weight (OR, 0.61; 95%CI, 0.51-0.70) were associated with a lower likelihood of this transition. No consistent associations were found for other lifestyle factors.

Conclusions

The prevalence of cardiovascular risk factors is high in economically active young Spanish adults. An unhealthy cardiovascular risk profile is inversely associated with an optimal lifestyle, but the latter is highly infrequent in this population.

Full English text available from:www.revespcardiol.org/en

这项研究旨在描述西班牙在职青壮年的心血管风险状况及其与生活方式的关系。方法从一家大型职业风险预防公司投保的全国经济活跃成年人队列中招募参与者（18-30 岁），并从常规医疗评估中获取数据。根据参与者是否存在糖尿病前期/糖尿病、高血压前期/高血压或高胆固醇血症，将其归类为心血管风险状况 "不健康 "的人群；如果完全不存在这些情况，则归类为心血管风险状况 "健康 "的人群。结果共有 78 421 名年轻成年人（27 ± 2 岁，36% 为女性）接受了基线评估。不健康 "的心血管风险状况普遍存在（18%），且与最佳生活方式（体重正常、经常运动、不饮酒/吸烟、睡眠良好）成反比（OR，0.64；95%CI，0.57-0.80）。只有 3.5%的参与者具备后一种条件。另一方面，对 44 776 名参与者进行的前瞻性分析（中位数随访时间=2[2-5]年）显示，有 2.0% 的人从 "健康 "状态转变为 "不健康 "状态。身体活跃（OR，0.95；95%CI，0.81-0.99）和体重正常（OR，0.61；95%CI，0.51-0.70）与这种转变的可能性较低有关。结论在西班牙从事经济活动的年轻人中，心血管风险因素的发生率很高。不健康的心血管风险状况与最佳生活方式成反比，但后者在这一人群中并不常见。英文全文见：www.revespcardiol.org/en。

{"title":"Estilo de vida y riesgo cardiovascular de jóvenes trabajadores: hallazgos en una cohorte de toda España","authors":"","doi":"10.1016/j.recesp.2024.02.006","DOIUrl":"10.1016/j.recesp.2024.02.006","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>This study aimed to describe the cardiovascular risk profile of working young adults from Spain and its association with lifestyle.</div></div><div><h3>Methods</h3><div>Participants (18-30 years) were recruited from a nationwide cohort of economically active adults insured by a large occupational risk prevention company, with data obtained from routine medical assessments<em>.</em> The participants were categorized as having an “unhealthy” cardiovascular risk profile based on the presence of prediabetes/diabetes, prehypertension/hypertension, or hypercholesterolemia, or a “healthy” profile if these conditions were completely absent. The association with lifestyle factors (weight, physical activity, sleeping characteristics, alcohol consumption, smoking) was assessed.</div></div><div><h3>Results</h3><div>A total of 78 421 young adults (27±2 years, 36% female) were evaluated at baseline. The “unhealthy” cardiovascular risk profile was prevalent (18%) and inversely associated (OR, 0.64; 95%<span>C</span>I, 0.57-0.80) with an optimal lifestyle (normal weight, regular physical activity, no drinking/smoking, and good sleep). The latter condition was found in only 3.5% of the participants. On the other hand, prospective analyses in 44 776 participants (median follow-up=2 [range 2-5] years) showed that 2.0% transitioned from a “healthy” to an “unhealthy” profile. Being physically active (OR, 0.95; 95%CI, 0.81-0.99) and having a normal weight (OR, 0.61; 95%CI, 0.51-0.70) were associated with a lower likelihood of this transition. No consistent associations were found for other lifestyle factors.</div></div><div><h3>Conclusions</h3><div>The prevalence of cardiovascular risk factors is high in economically active young Spanish adults. An unhealthy cardiovascular risk profile is inversely associated with an optimal lifestyle, but the latter is highly infrequent in this population.</div><div><em>Full English text available from</em>:<span><span>www.revespcardiol.org/en</span><svg><path></path></svg></span></div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 10","pages":"Pages 821-831"},"PeriodicalIF":5.9,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141281018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Corrección en el artículo de de Juan Bagudá et al. «Levosimendán ambulatorio repetitivo como puente al trasplante cardiaco», Rev Esp Cardiol. 2024;77:290-301 胡安-巴古达等人的文章 "重复性非卧床左西孟旦作为心脏移植的桥梁 "中的更正，Rev Esp Cardiol.2024;77:290-301

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-31 DOI: 10.1016/j.recesp.2024.05.009

引用次数: 0

Implicaciones de la miocardiopatía auricular en la incidencia de eventos cardioembólicos en pacientes con ictus criptogénico 心房心肌病对隐源性中风患者心栓塞事件发生率的影响。

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-24 DOI: 10.1016/j.recesp.2024.03.013

引用次数: 0

Richard S. Cooper 理查德-S-库珀

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-24 DOI: 10.1016/j.recesp.2024.05.011

引用次数: 0

Abertura y apertura 开放和共享

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-23 DOI: 10.1016/j.recesp.2023.07.004

引用次数: 0

IAMSEST en paciente de 16 años con colitis ulcerosa 一名 16 岁溃疡性结肠炎患者的非 ST 段抬高型急性心肌梗死

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-22 DOI: 10.1016/j.recesp.2024.05.006

引用次数: 0

¿Dispersión espaciotemporal «Reloaded»? ¿CFAE «Resurrections»? Una nueva entrega en la saga de identificación subjetiva de impulsores en fibrilación auricular 时空弥散 "重装上阵"？ CFAE "复活"？心房颤动主观冲动识别传奇的新篇章。

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-17 DOI: 10.1016/j.recesp.2024.03.009

引用次数: 0

Propuesta de modelo asistencial para el implante urgente de marcapasos 紧急起搏器植入术的拟议护理模式

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-13 DOI: 10.1016/j.recesp.2024.04.020

引用次数: 0

Revisión sistemática y metanálisis de la mortalidad en la miocardiopatía chagásica crónica frente a otras miocardiopatías: ¿mayor riesgo o ficción? 慢性恰加斯病心肌病与其他心肌病死亡率的系统回顾和荟萃分析：风险增加还是子虚乌有？

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-11 DOI: 10.1016/j.recesp.2024.02.022

Introduction and objectives

Although multiple studies suggest that chronic Chagas cardiomyopathy (CCC) has higher mortality than other cardiomyopathies, the absence of meta-analyses supporting this perspective limits the possibility of generating robust conclusions. The aim of this study was to systematically evaluate the current evidence on mortality risk in CCC compared with that of other cardiomyopathies.

Methods

PubMed/Medline and EMBASE were searched for studies comparing mortality risk between patients with CCC and those with other cardiomyopathies, including in the latter nonischemic cardiomyopathy (NICM), ischemic cardiomyopathy, and non-Chagas cardiomyopathy (nonCC). A random-effects meta-analysis was performed to combine the effects of the evaluated studies.

Results

A total of 37 studies evaluating 17 949 patients were included. Patients with CCC had a significantly higher mortality risk compared with patients with NICM (HR, 2.04; 95%CI, 1.60-2.60; I², 47%; 8 studies) and non-CC (HR, 2.26; 95%CI, 1.65-3.10; I², 71%; 11 studies), while no significant association was observed compared with patients with ischemic cardiomyopathy (HR, 1.72; 95%CI, 0.80-3.66; I², 69%; 4 studies) in the adjusted-measures meta-analysis.

Conclusions

Patients with CCC have an almost 2-fold increased mortality risk compared with individuals with heart failure secondary to other etiologies. This finding highlights the need for effective public policies and targeted research initiatives to optimally address the challenges of CCC.

Full English text available from:www.revespcardiol.org/en

引言和目的虽然多项研究表明慢性恰加斯氏心肌病（CCC）的死亡率高于其他心肌病，但由于缺乏支持这一观点的荟萃分析，因此无法得出可靠的结论。本研究的目的是系统评估目前有关 CCC 与其他心肌病死亡率风险比较的证据。研究方法在 PubMed/Medline 和 EMBASE 上搜索了比较 CCC 患者与其他心肌病患者死亡率风险的研究，包括后者中的非缺血性心肌病 (NICM)、缺血性心肌病和非恰加斯心肌病 (nonCC)。结果共纳入了 37 项研究，对 17 949 名患者进行了评估。与 NICM 患者（HR，2.04；95%CI，1.60-2.60；I2，47%；8 项研究）和非 CCC 患者（HR，2.26；95%CI，1.65-3.10；I2，71%；11 项研究）相比，CCC 患者的死亡风险明显更高，而与缺血性心肌病患者（HR，1.结论与继发于其他病因的心力衰竭患者相比，CCC 患者的死亡风险几乎增加了 2 倍。这一发现突出表明，需要有效的公共政策和有针对性的研究措施，以最佳方式应对 CCC 带来的挑战。英文全文可从以下网站获取：www.revespcardiol.org/en。

{"title":"Revisión sistemática y metanálisis de la mortalidad en la miocardiopatía chagásica crónica frente a otras miocardiopatías: ¿mayor riesgo o ficción?","authors":"","doi":"10.1016/j.recesp.2024.02.022","DOIUrl":"10.1016/j.recesp.2024.02.022","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Although multiple studies suggest that chronic Chagas cardiomyopathy (<span>CCC</span>) has higher mortality than other cardiomyopathies, the absence of meta-analyses supporting this perspective limits the possibility of generating robust conclusions. The aim of this study was to systematically evaluate the current evidence on mortality risk in CCC compared with that of other cardiomyopathies.</div></div><div><h3>Methods</h3><div>PubMed/Medline and EMBASE were searched for studies comparing mortality risk between patients with CCC and those with other cardiomyopathies, including in the latter nonischemic cardiomyopathy (NICM), ischemic cardiomyopathy, and non-Chagas cardiomyopathy (nonCC). A random-effects meta-analysis was performed to combine the effects of the evaluated studies.</div></div><div><h3>Results</h3><div>A total of 37 studies evaluating 17 949 patients were included. Patients with CCC had a significantly higher mortality risk compared with patients with NICM (HR, 2.04; 95%CI, 1.60-2.60; I<sup>2</sup>, 47%; 8 studies) and non-CC (HR, 2.26; 95%CI, 1.65-3.10; I<sup>2</sup>, 71%; 11 studies), while no significant association was observed compared with patients with ischemic cardiomyopathy (HR, 1.72; 95%CI, 0.80-3.66; I<sup>2</sup>, 69%; 4 studies) in the adjusted-measures meta-analysis.</div></div><div><h3>Conclusions</h3><div>Patients with CCC have an almost 2-fold increased mortality risk compared with individuals with heart failure secondary to other etiologies. This finding highlights the need for effective public policies and targeted research initiatives to optimally address the challenges of CCC.</div><div><em>Full English text available from</em>:<span><span>www.revespcardiol.org/en</span><svg><path></path></svg></span></div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"77 10","pages":"Pages 843-850"},"PeriodicalIF":5.9,"publicationDate":"2024-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141041657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Estado nutricional al ingreso y pronóstico en el shock cardiogénico 心源性休克患者入院时的营养状况和预后

IF 5.9 2区医学 Q2 Medicine

Revista espanola de cardiologia

Pub Date : 2024-05-10 DOI: 10.1016/j.recesp.2024.05.001

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

Revista espanola de cardiologia

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀